Tower Research Capital LLC (Trc) Brainstorm Cell Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 23,356 shares of BCLI stock, worth $53,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,356

Previous 86,579 73.02%

Holding current value

$53,251

Previous $29,000 82.76%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.22 - $0.42 $13,909 - $26,553	-63,223 Reduced 73.02%	23,356 $5,000
Q2 2024 Aug 13, 2024	BUY	$0.34 - $0.74 $25,695 - $55,924	75,574 Added 686.72%	86,579 $29,000
Q1 2024 May 15, 2024	SELL	$0.28 - $0.66 $2,024 - $4,772	-7,231 Reduced 39.65%	11,005 $6,000
Q4 2023 Feb 13, 2024	SELL	$0.15 - $0.4 $3,119 - $8,318	-20,795 Reduced 53.28%	18,236 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.2 - $2.08 $6,432 - $66,896	32,162 Added 468.22%	39,031 $7,000
Q2 2023 Aug 14, 2023	SELL	$2.0 - $3.2 $3,986 - $6,377	-1,993 Reduced 22.49%	6,869 $14,000
Q1 2023 May 09, 2023	BUY	$1.43 - $3.3 $11,162 - $25,759	7,806 Added 739.2%	8,862 $29,000
Q4 2022 Feb 10, 2023	BUY	$1.37 - $4.42 $1,446 - $4,667	1,056 New	1,056 $2,000
Q2 2022 Aug 15, 2022	BUY	$2.71 - $3.6 $15,024 - $19,958	5,544 New	5,544 $15,000
Q1 2022 May 12, 2022	SELL	$2.92 - $4.19 $10,050 - $14,421	-3,442 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.81 - $4.23 $9,672 - $14,559	3,442 New	3,442 $14,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $35,533 - $47,338	-11,805 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $25,821 - $58,808	7,463 Added 171.88%	11,805 $45,000
Q4 2020 Feb 16, 2021	SELL	$3.99 - $17.73 $76,967 - $342,011	-19,290 Reduced 81.63%	4,342 $20,000
Q3 2020 Nov 16, 2020	BUY	$11.19 - $16.92 $249,660 - $377,502	22,311 Added 1688.95%	23,632 $400,000
Q2 2020 Aug 13, 2020	SELL	$4.42 - $12.66 $45,826 - $131,258	-10,368 Reduced 88.7%	1,321 $15,000
Q1 2020 May 15, 2020	BUY	$4.01 - $8.88 $2,141 - $4,741	534 Added 4.79%	11,689 $54,000
Q4 2019 Feb 07, 2020	BUY	$3.62 - $4.29 $38,060 - $45,105	10,514 Added 1640.25%	11,155 $48,000
Q3 2019 Nov 05, 2019	BUY	$3.54 - $4.48 $2,269 - $2,871	641 New	641 $2,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $3.9 $2,050 - $2,683	-688 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$3.73 - $4.38 $2,607 - $3,061	-699 Reduced 50.4%	688 $3,000
Q2 2018 Aug 15, 2018	BUY	$3.12 - $5.19 $539 - $897	173 Added 14.25%	1,387 $5,000
Q1 2018 May 15, 2018	SELL	$3.01 - $3.77 $872 - $1,093	-290 Reduced 19.28%	1,214 $4,000
Q4 2017 Feb 09, 2018	SELL	$2.96 - $4.42 $849 - $1,268	-287 Reduced 16.02%	1,504 $6,000
Q3 2017 Nov 14, 2017	BUY	$3.98 - $4.36 $7,128 - $7,808	1,791	1,791 $7,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

10.8M

Call Options Held

160K

Put Options Held

30.5K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Brainstorm Cell Therapeutics Inc. Transaction History